GlassScriptPhysician profile
Kareem Deandre' Redmond
NPI 1720425754
$945.08
in general payments reported to CMS, 2019-2025
14 companies · $33.24 in 2025
The $33.24 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.08 · 2020: $79.13 · 2021: $50.07 · 2022: $519 · 2023: $11.07 · 2024: $163 · 2025: $33.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150 · Food and Beverage: $57.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150.00 |
| Food and Beverage | $57.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply LLC | $300.00 | 2022 | |
| Centrix INC | $221.19 | 2020-2022 | |
| Align Technology, INC. | $200.78 | 2022-2025 | Invisalign |
| A-Dec, INC. | $30.00 | 2019 | |
| Straumann USA LLC | $29.16 | 2019 | |
| Biolase, INC. | $26.70 | 2021 | |
| Ultradent Products INC | $25.50 | 2021-2025 | Opalescence |
| Nobel Biocare USA | $25.00 | 2021-2022 | |
| Dentsply Sirona INC | $18.75 | 2019 | |
| Kerr Corporation | $15.70 | 2022 | |
| Gc America INC. | $15.46 | 2020 | |
| Envista Holdings Corporation | $13.60 | 2025 | Artiste |
| Kulzer, LLC | $12.17 | 2019 | |
| Voco America INC. | $11.07 | 2023 | Admira Fusion X-Tra, Futurabond U, Grandio So |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kareem Redmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.